MRP4 overexpression was found be one of the causes of Cisplatin resistance in gastric cancer cells[166]; NRF2 dependant MRP 5 upregulation contributes to Doxorubicin resistance in hepatocarcinoma[93,167,168]. Here, NFE2L2 is linked to gastric cancer.